Recent News: NovaRx featured in articles in Biospace and The Union Tribune
NovaRx Corporation is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel cell-based therapeutic vaccines for the treatment of various cancers. The Company was originally founded in San Diego, California in May of 1997 in order to commercialize the award-winning research conducted between 1990 and 1997 by Dr. Habib Fakhrai and his associates at the Sidney Kimmel Cancer Center (“SKCC”) in San Diego and at the UCLA School of Medicine in Los Angeles. In September of 2004, the company relocated to a new 24,000 sq. foot facility located in the heart of San Diego’s thriving biotechnology community.
NovaRx Corporation is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel cell-based therapeutic vaccines for the treatment of various cancers. The Company was originally founded in San Diego, California in May of 1997 in order to commercialize the award-winning research conducted between 1990 and 1997 by Dr. Habib Fakhrai and his associates at the Sidney Kimmel Cancer Center (“SKCC”) in San Diego and at the UCLA School of Medicine in Los Angeles. In September of 2004, the company relocated to a new 24,000 sq. foot facility located in the heart of San Diego’s thriving biotechnology community.
